Article
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Nature - 1 Mar 2020
Suskiewicz Marcin J, Zobel Florian, Ogden Tom E H, Fontana Pietro, Ariza Antonio, Yang Ji-Chun, Zhu Kang, Bracken Lily, Hawthorne William J, Ahel Dragana, Neuhaus David, Ahel Ivan
Abstract excerpt
The anti-cancer drug target poly(ADP-ribose) polymerase 1 (PARP1) and its close homologue, PARP2, are early responders to DNA damage in human cells1,2. After binding to genomic lesions, these enzymes use NAD+ to modify numerous proteins with mono- and poly(ADP-ribose) signals that are important for the subsequent decompaction of chromatin and the recruitment of repair factors3,4. These post-translational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
